Mind Medicine Stock Alpha and Beta Analysis

MNMD Stock  USD 6.35  0.04  0.63%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mind Medicine. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mind Medicine over a specified time horizon. Remember, high Mind Medicine's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mind Medicine's market risk premium analysis include:
Beta
1.32
Alpha
0.16
Risk
5.88
Sharpe Ratio
(0.02)
Expected Return
(0.1)
Please note that although Mind Medicine alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Mind Medicine did 0.16  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Mind Medicine stock's relative risk over its benchmark. Mind Medicine has a beta of 1.32  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mind Medicine will likely underperform. At present, Mind Medicine's Tangible Asset Value is projected to increase significantly based on the last few years of reporting. The current year's Tangible Book Value Per Share is expected to grow to 6.26, whereas Enterprise Value Over EBITDA is forecasted to decline to (2.41).

Enterprise Value

250.45 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Mind Medicine Backtesting, Mind Medicine Valuation, Mind Medicine Correlation, Mind Medicine Hype Analysis, Mind Medicine Volatility, Mind Medicine History and analyze Mind Medicine Performance.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

Mind Medicine Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mind Medicine market risk premium is the additional return an investor will receive from holding Mind Medicine long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mind Medicine. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mind Medicine's performance over market.
α0.16   β1.32

Mind Medicine expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mind Medicine's Buy-and-hold return. Our buy-and-hold chart shows how Mind Medicine performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Mind Medicine Market Price Analysis

Market price analysis indicators help investors to evaluate how Mind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mind Medicine shares will generate the highest return on investment. By understating and applying Mind Medicine stock market price indicators, traders can identify Mind Medicine position entry and exit signals to maximize returns.

Mind Medicine Return and Market Media

The median price of Mind Medicine for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 7.16 with a coefficient of variation of 10.49. The daily time series for the period is distributed with a sample standard deviation of 0.76, arithmetic mean of 7.29, and mean deviation of 0.57. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Disposition of 4519 shares by Sullivan Mark of Mind Medicine at 7.43 subject to Rule 16b-3
12/26/2024
2
Disposition of 32595 shares by Halperin Wernli Miri of Mind Medicine at 6.17 subject to Rule 16b-3
01/21/2025
3
Mind Medicine Stock Rises As Evercore Projects 200 percent Upside On LSD Formulation Retail Turns Bullish - MSN
01/28/2025
4
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
01/30/2025
5
Mind Medicine Trading 5.5 percent Higher Time to Buy
02/05/2025
6
Mind Medicine Stock Surges on RFK Jr.s HHS Confirmation
02/14/2025
7
MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
02/20/2025
8
Warren Buffetts State of the Market
03/03/2025
9
MindMed to Present at Leerinks Global Healthcare Conference 2025
03/04/2025
10
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
03/06/2025
11
Mind Medicine Inc Q4 2024 Earnings Call Highlights Strategic Advances and Financial ...
03/07/2025
12
Acquisition by Liao Carrie of 50000 shares of Mind Medicine subject to Rule 16b-3
03/12/2025

About Mind Medicine Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mind or other stocks. Alpha measures the amount that position in Mind Medicine has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
PB Ratio2.031.79
Capex To Depreciation53.9351.24

Mind Medicine Upcoming Company Events

As portrayed in its financial statements, the presentation of Mind Medicine's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mind Medicine's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mind Medicine's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mind Medicine. Please utilize our Beneish M Score to check the likelihood of Mind Medicine's management manipulating its earnings.
14th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Mind Medicine

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:
Mind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mind Medicine technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mind Medicine trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...